Infection of influenza virus neuraminidasevaccinated mice with homologous influenza virus leads to strong protection against heterologous influenza viruses

Journal of General Virology

Volumn 95, Issue , 2014, Pages 2627-2637

  He, Biao ^a   Chang, Haiyan ^a   Liu, Zhihua ^a   Huang, Chaoyang ^a   Liu, Xueying ^b   Zheng, Dan ^b   Fang, Fang ^a   Sun, Bing ^c   Chen, Ze ^a,b  

^a HUNAN NORMAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS   (China)

^c INSTITUTE PASTEUR OF SHANGHAI   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INFLUENZA VIRUS NEURAMINIDASE; UNCLASSIFIED DRUG; VIRUS SIALIDASE; SIALIDASE; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA VIRUS; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA IMMUNIZATION; EXPERIMENTAL INFECTION; FEMALE; HETEROLOGOUS IMMUNITY; HUMORAL IMMUNITY; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA A VIRUS (A/CHICKEN/HENAN/12/2004 (H5N1)); INFLUENZA A VIRUS (A/CHICKEN/JIANGSU/7/2002 (H9N2)); INFLUENZA A VIRUS (A/GUIZHOU/54/89XA/PR/8/34 (A/GUIZHOU-X) (H3N2)); INFLUENZA A VIRUS (A/PUERTO RICO/8/1934(H1N1)); INFLUENZA A VIRUS (A/REASSORTANT/NYMC X-179A (PH1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H9N2; LD 50; LETHAL DOSE; MOUSE; NONHUMAN; SURVIVAL RATE; VIRUS IMMUNITY; VIRUS LOAD; ANIMAL; BAGG ALBINO MOUSE; CLASSIFICATION; ENZYMOLOGY; GENETIC REASSORTMENT; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; INFLUENZA VIRUS A; ORTHOMYXOVIRIDAE INFECTIONS; ORTHOMYXOVIRUS; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; FEMALE; IMMUNITY, HUMORAL; INFLUENZA A VIRUS; INFLUENZA VACCINES; MICE; MICE, INBRED BALB C; NEURAMINIDASE; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; REASSORTANT VIRUSES; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES, DNA; VIRAL LOAD;

EID: 84910674791     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.067736-0     Document Type: Article

References (45)

1. Carrat, F. & Flahault, A. (2007). Influenza vaccine: the challenge of antigenic drift. Vaccine 25, 6852-6862.
2. Carter, D. M., Bloom, C. E., Nascimento, E. J., Marques, E. T., Craigo, J. K., Cherry, J. L., Lipman, D. J. & Ross, T. M. (2013). Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus. J Virol 87, 1400-1410.
3. Chang, H., Huang, C., Wu, J., Fang, F., Zhang, W., Wang, F. & Chen, Z. (2010). A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus. Virol J 7, 197.
4. Chen, Z., Sahashi, Y., Matsuo, K., Asanuma, H., Takahashi, H., Iwasaki, T., Suzuki, Y., Aizawa, C., Kurata, T. & Tamura, S. (1998). Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine 16, 1544-1549.
5. Chen, Z., Kadowaki, S., Hagiwara, Y., Yoshikawa, T., Matsuo, K., Kurata, T. & Tamura, S. (2000). Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine 18, 3214-3222.
6. Chen, J., Fang, F., Li, X., Chang, H. & Chen, Z. (2005). Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. Vaccine 23, 4322-4328.
7. Chen, Q., Kuang, H., Wang, H., Fang, F., Yang, Z., Zhang, Z., Zhang, X. & Chen, Z. (2009). Comparing the ability of a series of viral protein-expressing plasmid DNAs to protect against H5N1 influenza virus. Virus Genes 38, 30-38.
8. Colman, P. M. & Ward, C. W. (1985). Structure and diversity of influenza virus neuraminidase. Curr Top Microbiol Immunol 114, 177-255.
9. Couceiro, J. N., Paulson, J. C. & Baum, L. G. (1993). Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res 29, 155-165.
10. Effros, R. B., Doherty, P. C., Gerhard, W. & Bennink, J. (1977). Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J Exp Med 145, 557-568.
11. Epstein, S. L. (2006). Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 193, 49-53.
12. Epstein, S. L., Kong, W. P., Misplon, J. A., Lo, C. Y., Tumpey, T. M., Xu, L. & Nabel, G. J. (2005). Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. Vaccine 23, 5404-5410.
13. Fan, J., Liang, X., Horton, M. S., Perry, H. C., Citron, M. P., Heidecker, G. J., Fu, T. M., Joyce, J., Przysiecki, C. T. & other authors (2004). Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys. Vaccine 22, 2993-3003.
14. Fang, F., Cai, X. Q., Chang, H. Y., Wang, H. D., Yang, Z. D. & Chen, Z. (2008). Protection abilities of influenza B virus DNA vaccines expressing hemagglutinin, neuraminidase, or both in mice. Acta Virol 52, 107-112.
15. Fereidouni, S. R., Starick, E., Beer, M., Wilking, H., Kalthoff, D., Grund, C., Häuslaigner, R., Breithaupt, A., Lange, E. & Harder, T. C. (2009). Highly pathogenic avian influenza virus infection of mallards with homo-and heterosubtypic immunity induced by low pathogenic avian influenza viruses. PLoS ONE 4, e6706.
16. Furuya, Y., Chan, J., Regner, M., Lobigs, M., Koskinen, A., Kok, T., Manavis, J., Li, P., Müllbacher, A. & Alsharifi, M. (2010). Cytotoxic T cells are the predominant players providing cross-protective immunity induced by gamma-irradiated influenza A viruses. J Virol 84, 4212-4221.
17. Gambaryan, A. S., Piskarev, V. E., Yamskov, I. A., Sakharov, A. M., Tuzikov, A. B., Bovin, N. V., Nifant’ev, N. E. & Matrosovich, M. N. (1995). Human influenza virus recognition of sialyloligosaccharides. FEBS Lett 366, 57-60.
18. Gao, R., Cao, B., Hu, Y., Feng, Z., Wang, D., Hu, W., Chen, J., Jie, Z., Qiu, H. & other authors (2013). Human infection with a novel avianorigin influenza A (H7N9) virus. N Engl J Med 368, 1888-1897.
19. Garten, R. J., Davis, C. T., Russell, C. A., Shu, B., Lindstrom, S., Balish, A., Sessions, W. M., Xu, X., Skepner, E. & other authors (2009). Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325, 197-201.
20. Guo, L., Zheng, M., Ding, Y., Li, D., Yang, Z., Wang, H., Chen, Q., Sui, Z., Fang, F. & Chen, Z. (2010). Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein. Arch Virol 155, 1765-1775.
21. Guo, H., Santiago, F., Lambert, K., Takimoto, T. & Topham, D. J. (2011). T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. J Virol 85, 448-455.
22. Haanen, J. B., Wolkers, M. C., Kruisbeek, A. M. & Schumacher, T. N. (1999). Selective expansion of cross-reactive CD8+ memory T cells by viral variants. J Exp Med 190, 1319-1328.
23. Harley, V. R., Ward, C. W. & Hudson, P. J. (1989). Molecular cloning and analysis of the N5 neuraminidase subtype from an avian influenza virus. Virology 169, 239-243.
24. Heinen, P. P., de Boer-Luijtze, E. A. & Bianchi, A. T. (2001). Respiratory and systemic humoral and cellular immune responses of pigs to a heterosubtypic influenza A virus infection. J Gen Virol 82, 2697-2707.
25. Johansson, B. E., Bucher, D. J. & Kilbourne, E. D. (1989). Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J Virol 63, 1239-1246.
26. Kreijtz, J. H., Bodewes, R., van den Brand, J. M., de Mutsert, G., Baas, C., van Amerongen, G., Fouchier, R. A., Osterhaus, A. D. & Rimmelzwaan, G. F. (2009). Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus. Vaccine 27, 4983-4989.
27. LaMere, M. W., Lam, H. T., Moquin, A., Haynes, L., Lund, F. E., Randall, T. D. & Kaminski, D. A. (2011). Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. J Immunol 186, 4331-4339.
28. Liang, S., Mozdzanowska, K., Palladino, G. & Gerhard, W. (1994). Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity. J Immunol 152, 1653-1661.
29. Martínez, C., del Rio, L., Portela, A., Domingo, E. & Ortín, J. (1983). Evolution of the influenza virus neuraminidase gene during drift of the N2 subtype. Virology 130, 539-545.
30. McMichael, A. J., Gotch, F. M., Noble, G. R. & Beare, P. A. (1983). Cytotoxic T-cell immunity to influenza. N Engl J Med 309, 13-17.
31. Neirynck, S., Deroo, T., Saelens, X., Vanlandschoot, P., Jou, W. M. & Fiers, W. (1999). A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 5, 1157-1163.
32. Neumann, G., Noda, T. & Kawaoka, Y. (2009). Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459, 931-939.
33. Ozawa, T., Jin, A., Tajiri, K., Takemoto, M., Okuda, T., Shiraki, K., Kishi, H. & Muraguchi, A. (2011). Characterization of a fully human monoclonal antibody against extracellular domain of matrix protein 2 of influenza A virus. Antiviral Res 91, 283-287.
34. Qiu, M., Fang, F., Chen, Y., Wang, H., Chen, Q., Chang, H., Wang, F., Wang, H., Zhang, R. & Chen, Z. (2006). Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin-or neuraminidase-expressing DNA in BALB/c mice. Biochem Biophys Res Commun 343, 1124-1131.
35. Saha, S., Yoshida, S., Ohba, K., Matsui, K., Matsuda, T., Takeshita, F., Umeda, K., Tamura, Y., Okuda, K. & other authors (2006). A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus. Virology 354, 48-57.
36. Sambhara, S. & Poland, G. A. (2010). H5N1 avian influenza: preventive and therapeutic strategies against a pandemic. Annu Rev Med 61, 187-198.
37. Sandbulte, M. R., Jimenez, G. S., Boon, A. C., Smith, L. R., Treanor, J. J. & Webby, R. J. (2007). Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 4, e59.
38. Seo, S. H. & Webster, R. G. (2001). Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. J Virol 75, 2516-2525.
39. Sui, Z., Chen, Q., Fang, F., Zheng, M. & Chen, Z. (2010a). Crossprotection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant. Vaccine 28, 7690-7698.
40. Sui, Z., Chen, Q., Wu, R., Zhang, H., Zheng, M., Wang, H. & Chen, Z. (2010b). Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant. Arch Virol 155, 535-544.
41. Watabe, S., Xin, K. Q., Ihata, A., Liu, L. J., Honsho, A., Aoki, I., Hamajima, K., Wahren, B. & Okuda, K. (2001). Protection against influenza virus challenge by topical application of influenza DNA vaccine. Vaccine 19, 4434-4444.
42. WHO (2002). WHO Manual on Animal Influenza Diagnosis and Surveillance. http://www.who.int/csr/resources/publications/influenza/en/whocdscsrncs20025rev.pdf.
43. WHO (2014). Antigenic and genetic characteristics of zoonotic influenza viruses and candidate vaccine viruses developed for potential use in human vaccines. http://www.who.int/influenza/vaccines/virus/201402_h5h7h9h10_vaccinevirusupdate.pdf?ua=1
44. Zhang, F., Fang, F., Chang, H., Peng, B., Wu, J., Chen, J., Wang, H. & Chen, Z. (2013). Comparison of protection against H5N1 influenza virus in mouse offspring provided by maternal vaccination with HA DNA and inactivated vaccine. Arch Virol 158, 1253-1265.
45. Zheng, L., Wang, F., Yang, Z., Chen, J., Chang, H. & Chen, Z. (2009). A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice. BMC Infect Dis 9, 17.